25 May 2013
Keywords: shire, submits, eu, maa, ulcerative, colitis, drug
Article | 13 February 2006
UK drugmaker Shire has submitted a Marketing Authorization Application to European regulators for SPD476, an investigational compound being
studied for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 February 2006
24 May 2013
© 2013 thepharmaletter.com